Interestingly, though not significant the opposite trend was observed in Ethiopian HIV patients, i.e., a trend of having higher plasma efavirenz concentration during rifampicin based anti-TB cotreatment particularly in CYP2B6*6 carriers. Here, CYP2B6 is linked to tuberculosis.